Skip to main content
. Author manuscript; available in PMC: 2009 Jul 14.
Published in final edited form as: Cancer Res. 2008 Apr 1;68(7):2286–2291. doi: 10.1158/0008-5472.CAN-07-1349

Figure 2.

Figure 2

Characterization of IPL-F binding to HPN-expressing cells. A. IPL-F discriminates between HPN expressing prostate cancer cell lines HPN-PC3 and LNCaP and non-expressing cell lines PC3 and DU145. B. IPL-F binds to HPN. Anti-HPN antibody competes for IPL-F binding to HPN-PC3 cells. Green Histogram: HPN-PC3 cells incubated with IPL-F, Gray Histogram: HPN-PC3 cells incubated with anti-HPN antibody and IPL-F. C. Competition assay. IPL-• were competed from HPN-PC3 cells with increasing concentrations of IPL-F whereas ScP was unable to compete for binding at assayed concentrations of peptide